Table 1 Patient characteristics of MSC group and non-MSC group
|  | MSC group (n = 47) | Non-MSC group (n = 60) | p value |
|---|---|---|---|
No. (%) | No. (%) | ||
Age (year) | |||
Mean ± SD (range) | 6.19 ± 3.04 (1.10–15) | 6.54 ± 2.94 (1.10–15) | 0.608 |
 ≤ 7 | 33 (70.21) | 42 (70.00) | 0.981 |
 > 7 | 14 (29.79) | 18 (30.00) |  |
Sex | 0.778 | ||
 Male | 31 (65.96) | 38 (63.33) |  |
 Female | 16 (34.04) | 22 (36.67) |  |
Pneumonia | 0.306 | ||
 Non-severe | 31 (65.96) | 45 (75) |  |
 Severe | 16 (34.04) | 15 (25) |  |
HSC sourcea | 0.454 | ||
 Peripheral blood | 41 (87.23) | 55 (91.67) |  |
 Umbilical cord blood | 6 (12.77) | 5 (8.33) |  |
HSC donor typeb | 0.800 | ||
 Matched | 27 (57.45) | 33(55.00) |  |
 Mismatched | 20 (42.55) | 27 (45.00) |  |
Primary diseases | 0.176 | ||
 Thalassemia | 36 (76.60) | 52 (86.67) |  |
 Others | 11 (23.40) | 8(13.33) |  |
Interval daysc | |||
 ≥ 100 | 20 (42.55) | 19 (31.67) | 0.246 |
 < 100 | 27 (57.45) | 41 (68.33) |  |
Virus serostatus | 0.725 | ||
 Negative | 29 (61.70) | 39 (65.00) |  |
 Positive | 18 (38.30) | 21 (35.00) |  |
Virus (serostatus + BAL)d | |||
 Negative | 23 (48.94) | 33 (55.00) | 0.533 |
 Positive | 24 (51.06) | 27 (45.00) |  |
Bacteria/fungi | 0.454 | ||
 Negative | 41 (87.23) | 55 (91.67) |  |
 Positive | 6 (12.77) | 5 (8.33) |  |
MSC infusion times | |||
 Mean ± SD (Median, range) | 4.04 ± 2.11 (4, 1–11) |  |  |